Desmoplastic infantile astrocytoma with atypical phenotype, PTEN homozygous deletion and BRAF V600E mutation

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Desmoplastic infantile astrocytoma with atypical phenotype, PTEN homozygous deletion and BRAF V600E mutation ; volume:10 ; number:1 ; day:20 ; month:6 ; year:2022 ; pages:1-7 ; date:12.2022
Acta Neuropathologica Communications ; 10, Heft 1 (20.6.2022), 1-7, 12.2022

Creator: Megías, Javier
San-Miguel, Teresa
Sánchez, Mirian
Navarro, Lara
Monleón, Daniel
Calabuig-Fariñas, Silvia
Morales, José Manuel
Muñoz-Hidalgo, Lisandra
Roldán, Pedro
Cerdá-Nicolás, Miguel
López-Ginés, Concha

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-022-01392-x

URN: urn:nbn:de:101:1-2022081308465253970414

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Megías, Javier
San-Miguel, Teresa
Sánchez, Mirian
Navarro, Lara
Monleón, Daniel
Calabuig-Fariñas, Silvia
Morales, José Manuel
Muñoz-Hidalgo, Lisandra
Roldán, Pedro
Cerdá-Nicolás, Miguel
López-Ginés, Concha
SpringerLink (Online service)

Other Objects (12)

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

A novel GIT2-BRAF fusion in pilocytic astrocytoma

Hochschulschrift

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

A novel GIT2-BRAF fusion in pilocytic astrocytoma

Hochschulschrift

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

A novel GIT2-BRAF fusion in pilocytic astrocytoma

Hochschulschrift

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Desmoplastic infantile astrocytoma with atypical phenotype, PTEN homozygous deletion and BRAF V600E mutation

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

A novel GIT2-BRAF fusion in pilocytic astrocytoma

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

A novel GIT2-BRAF fusion in pilocytic astrocytoma

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

A novel GIT2-BRAF fusion in pilocytic astrocytoma

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate

Related objects

Reset password